SHALLCROSS STEVEN A has filed 10 insider transactions across 1 company since December 2022.
Most recent transaction: a grant/award of 475000 shares of Theriva Biologics, Inc. ($TOVX) on January 05, 2026.
Activity breakdown: 7 open-market purchases and 0 sales.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Jan. 5, 2026 | Theriva Biologics, Inc. | $TOVX | SHALLCROSS STEVEN A | CEO and CFO | A | Stock Options (right to buy) | 475000 | $0.00 | 475,000.0000 | 9,676,521 | 9999.99% | 4.91% |
| April 29, 2025 | Theriva Biologics, Inc. | $TOVX | SHALLCROSS STEVEN A | CEO and CFO | A | Stock Options (right to buy) | 190000 | $0.00 | 190,000.0000 | 2,782,449 | 9999.99% | 6.83% |
| Dec. 14, 2023 | Theriva Biologics, Inc. | $TOVX | SHALLCROSS STEVEN A | CEO and CFO | A | Stock Options (right to buy) | 700000 | $0.00 | 700,000.0000 | 681,708 | 9999.99% | 100.00% |
| June 7, 2023 | Theriva Biologics, Inc. | $TOVX | SHALLCROSS STEVEN A | CEO and CFO | P | Common Stock | 14000 | $0.69 | 250,000.0000 | 15,124,061 | 5.93% | 0.09% |
| June 6, 2023 | Theriva Biologics, Inc. | $TOVX | SHALLCROSS STEVEN A | CEO and CFO | P | Common Stock | 26000 | $0.63 | 236,000.0000 | 15,124,061 | 12.38% | 0.17% |
| Feb. 10, 2023 | Theriva Biologics, Inc. | $TOVX | SHALLCROSS STEVEN A | CEO and CFO | P | Common Stock | 25000 | $1.04 | 210,000.0000 | 15,327,328 | 13.51% | 0.16% |
| Feb. 2, 2023 | Theriva Biologics, Inc. | $TOVX | SHALLCROSS STEVEN A | CEO and CFO | P | Common Stock | 25000 | $0.94 | 185,000.0000 | 15,327,328 | 15.63% | 0.16% |
| Jan. 25, 2023 | Theriva Biologics, Inc. | $TOVX | SHALLCROSS STEVEN A | CEO and CFO | P | Common Stock | 25000 | $0.87 | 160,000.0000 | 15,327,328 | 18.52% | 0.16% |
| Jan. 20, 2023 | Theriva Biologics, Inc. | $TOVX | SHALLCROSS STEVEN A | CEO and CFO | P | Common Stock | 25000 | $0.75 | 135,000.0000 | 15,327,328 | 22.73% | 0.16% |
| Dec. 29, 2022 | Theriva Biologics, Inc. | $TOVX | SHALLCROSS STEVEN A | CEO and CFO | P | Common Stock | 100000 | $0.44 | 110,000.0000 | 15,844,061 | 1000.00% | 0.63% |